These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ceftazidime/Tobramycin Co-Loaded Chitosan-Coated Zein Nanoparticles against Antibiotic-Resistant and Biofilm-Producing Campos LAA; Neto AFS; Scavuzzi AML; Lopes ACS; Santos-Magalhães NS; Cavalcanti IMF Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543106 [TBL] [Abstract][Full Text] [Related]
3. Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model. Wei J; Zhou S; Gu H; Tong K Clin Orthop Relat Res; 2023 Jan; 481(1):177-189. PubMed ID: 36135966 [TBL] [Abstract][Full Text] [Related]
4. Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling. Bilal H; Tait JR; Lang Y; Zhou J; Bergen PJ; Peleg AY; Bulitta JB; Oliver A; Nation RL; Landersdorfer CB Antimicrob Agents Chemother; 2022 Mar; 66(3):e0220321. PubMed ID: 35041509 [TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneumonia. Croisier D; Martha B; Piroth L; Chavanet P Int J Antimicrob Agents; 2008 Dec; 32(6):494-8. PubMed ID: 18804348 [TBL] [Abstract][Full Text] [Related]
7. In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa. Laverdière M; Gallimore B; Restieri C; Poonia K; Chow AW Diagn Microbiol Infect Dis; 1994 May; 19(1):39-46. PubMed ID: 7956011 [TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization, and Evaluation of Zinc Oxide Nanoparticles Suspension as an Antimicrobial Media for Daily Use Soft Contact Lenses. Shayani Rad M; Sabeti Z; Mohajeri SA; Fazly Bazzaz BS Curr Eye Res; 2020 Aug; 45(8):931-939. PubMed ID: 31847595 [TBL] [Abstract][Full Text] [Related]
9. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010 [No Abstract] [Full Text] [Related]
10. Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. Plasencia V; Borrell N; Maciá MD; Moya B; Pérez JL; Oliver A Antimicrob Agents Chemother; 2007 Jul; 51(7):2574-81. PubMed ID: 17470655 [TBL] [Abstract][Full Text] [Related]
11. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer. Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183 [No Abstract] [Full Text] [Related]
12. Microbiological interaction studies between ceftazidime-avibactam and pulmonary surfactant and between ceftazidime-avibactam and antibacterial agents of other classes. Dallow J; Otterson LG; Huband MD; Krause KM; Nichols WW Int J Antimicrob Agents; 2014 Dec; 44(6):552-6. PubMed ID: 25293578 [TBL] [Abstract][Full Text] [Related]
13. Chimeric Tobramycin-Based Adjuvant TOB-TOB-CIP Potentiates Fluoroquinolone and β-Lactam Antibiotics against Multidrug-Resistant Dhiman S; Ramirez D; Li Y; Kumar A; Arthur G; Schweizer F ACS Infect Dis; 2023 Apr; 9(4):864-885. PubMed ID: 36917096 [TBL] [Abstract][Full Text] [Related]
14. The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria. Zhou H; Xu M; Guo W; Yao Z; Du X; Chen L; Sun Y; Shi S; Cao J; Zhou T Microbiol Spectr; 2022 Dec; 10(6):e0226522. PubMed ID: 36314964 [TBL] [Abstract][Full Text] [Related]
15. Tobramycin mediated silver nanospheres/graphene oxide composite for synergistic therapy of bacterial infection. Ullah S; Ahmad A; Subhan F; Jan A; Raza M; Khan AU; Rahman AU; Khan UA; Tariq M; Yuan Q J Photochem Photobiol B; 2018 Jun; 183():342-348. PubMed ID: 29763756 [TBL] [Abstract][Full Text] [Related]
16. Ceftazidime-Decorated Gold Nanoparticles: a Promising Strategy against Clinical Ceftazidime-Avibactam-Resistant Huang Z; Liu H; Zhang X; Tang M; Lin Y; Feng L; Ye J; Zhou T; Chen L Antimicrob Agents Chemother; 2023 Jul; 67(7):e0026223. PubMed ID: 37358468 [TBL] [Abstract][Full Text] [Related]
19. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria. Wang J; Kutter JP; Mu H; Moodley A; Yang M Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003 [TBL] [Abstract][Full Text] [Related]
20. Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Di Bonaventura G; Lupetti V; De Fabritiis S; Piccirilli A; Porreca A; Di Nicola M; Pompilio A Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]